Sambrinvest

Rounds

• E Enodia TherapeuticsDevelops small molecules that degrade disease proteins at synthesis via SEC61 translocon $24.2MSeed · 8 Jan
• E ElkedoniaDevelops non-hallucinogenic neuroplastogens for treatment-resistant depression $12.9MSeed · 11 Jun

No round matches these filters.

Often invests with

• Angelini Ventures1
• Argobio1
• Argobio Studio1
• Bpifrance1
• Capital Grand Est1
• Carma Fund1
• Elaia1
• French Tech Seed (Bpifrance)1